MetaCap

Alterity Therapeutics Limited ADR Company Profile

NASDAQ: ATHEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.52-0.135 (-8.16%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Alterity Therapeutics at a glance

Alterity Therapeutics Limited ADR (NASDAQ: ATHE) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Melbourne, VIC, Australia. Alterity Therapeutics is led by Dr. David A. Stamler M.D. and employs about 11 people. At a market capitalization of $29.0 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001131343, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Alterity Therapeutics do?

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as bioMUSE, biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Business description based on the company's public filings.

Company information

Legal name
Alterity Therapeutics Limited ADR
Ticker
NASDAQ: ATHE
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. David A. Stamler M.D.
Employees
11
Headquarters
500 Collins Street, Melbourne, VIC, Australia
Phone
61 3 9349 4906
Market cap
$29.02M
SEC CIK
0001131343

Companies similar to Alterity Therapeutics

ATHE peer companies
CompanyPrice% ChgMarket capCompare
RNTXRein Therapeutics Inc.0.3369-8.38%$29.06Mvs ATHE
AYTUAytu BioPharma Inc.2.660.00%$28.91Mvs ATHE
NNVCNanoViricides Inc.1.14-2.56%$29.13Mvs ATHE
NXTCNextCure Inc.6.45-4.87%$29.53Mvs ATHE
PMNProMIS Neurosciences Inc.3.16-1.56%$28.43Mvs ATHE
SERSerina Therapeutics Inc.1.12-6.67%$29.76Mvs ATHE
EDSAEdesa Biotech Inc.2.00-8.05%$27.02Mvs ATHE
NSRXNasus Pharma Ltd.2.29-10.20%$26.82Mvs ATHE

Related